GlassScriptPhysician profile
Sonia Sibaja
NPI 1710062773
$2,329.57
in general payments reported to CMS, 2019-2025
23 companies · $451 in 2025
The $451 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $280 · 2021: $547 · 2022: $213 · 2023: $157 · 2024: $131 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $566.47 | 2019-2024 | Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $269.38 | 2020-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $242.91 | 2019 | |
| Amgen INC. | $218.15 | 2019-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.18 | 2021-2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $134.47 | 2021-2025 | Zoryve |
| Merck Sharp & Dohme LLC | $96.80 | 2019-2021 | |
| Pfizer INC. | $95.95 | 2019-2025 | |
| Ibsa Pharma INC. | $95.41 | 2020-2022 | |
| Exact Sciences Corporation | $57.32 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $48.97 | 2025 | |
| Phadia US INC. | $47.45 | 2022-2025 | Immunocap |
| Cranial Technologies, INC | $46.06 | 2019-2021 | |
| Glaxosmithkline, LLC. | $37.75 | 2019 | |
| Hologic Sales and Service, LLC | $36.91 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36.29 | 2019 | |
| Inspire Medical Systems, INC. | $22.94 | 2024 | Inspire |
| Novo Nordisk INC | $20.48 | 2023 | Ozempic, Rybelsus |
| Idorsia Pharmaceuticals US INC | $19.81 | 2022 | |
| Astellas Pharma US INC | $19.17 | 2024 | Veozah |
| Sanofi Pasteur INC. | $17.63 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.85 | 2024 | Voquezna |
| Acerus Pharmaceuticals Corporation | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Sibaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.